← Leaderboards
Steven Bennett Chinn
University Of Michigan At Ann Arbor
$1,561,761
Attributed
$2,921,099
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $689.3K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,921,099 · 2
By mechanism
U01$2,039,007 · 1
K08$882,092 · 1
Top collaborators
- Yu Leo Lei3 shared
- Thomas D Wang3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Erle S Robertson$33,256,575
- Yi Sun$9,791,676
- Sunny Y Wong$7,036,918
- Xudong Fan$6,206,272
- Johann Eli Gudjonsson$13,584,665
Others in their field
Other Emerging Leaders on “Cohort”
- Leonard Freedman · Leidos Biomedical Research, Inc.$70,225,348
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Scott Hensley · University Of Pennsylvania$47,346,110
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
CohortDiagnosticHigh RiskTechnologyMalignant NeoplasmsBaseEventHead And Neck Squamous Cell CarcinomaMolecularProgramsPathway InteractionsOral CavityMalignant Mouth NeoplasmFrequenciesPatient CareCancer GeneticsEducationEpidemiologyDna RepairBioinformaticsDyskeratosis CongenitaEtiologyCell LineDatabases
Grant awards (7)
Advancing On-Slide and Optical Biopsy Tools to Detect High-Risk Oral Premalignancy$674,252
U01 · FY2025 · DE
Advancing On-Slide and Optical Biopsy Tools to Detect High-Risk Oral Premalignancy$675,425
U01 · FY2024 · DE
Advancing On-Slide and Optical Biopsy Tools to Detect High-Risk Oral Premalignancy$689,330
U01 · FY2023 · DE
Integrated Analysis of Germline and Somatic Mutations in Young, Low-Risk and Older, High-Risk Oral Cavity Cancer$130,572
K08 · FY2021 · CA · contact PI
Integrated Analysis of Germline and Somatic Mutations in Young, Low-Risk and Older, High-Risk Oral Cavity Cancer$250,436
K08 · FY2020 · CA · contact PI
Integrated Analysis of Germline and Somatic Mutations in Young, Low-Risk and Older, High-Risk Oral Cavity Cancer$250,507
K08 · FY2019 · CA · contact PI
Integrated Analysis of Germline and Somatic Mutations in Young, Low-Risk and Older, High-Risk Oral Cavity Cancer$250,577
K08 · FY2018 · CA · contact PI